http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115201134-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-775 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-78 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-78 |
| filingDate | 2022-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-115201134-B |
| titleOfInvention | A creatinine detection kit against the interference of picatanol and its application |
| abstract | The invention discloses a creatinine detection kit against the interference of picatanol and its application, and belongs to the field of medical biotechnology. The kit includes independently packaged R1 reagent and R2 reagent, and the R1 reagent contains 2, 2, 6, 6‑tetramethylpiperidine 1‑oxyl radical, sarcosine oxidase, creatine amidinohydrolase, catalase, and N‑ethyl‑N‑(3‑sulfopropyl)‑3‑methoxy Aniline, R2 reagent contains creatinine amide hydrolase, peroxidase, coupling agent. Using the kit of the invention to measure the creatinine content in human serum does not require pretreatment of samples, so that the determination of creatinine will not be affected by piceatanol. |
| priorityDate | 2022-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 281.